Brief: Aslan Pharma Receives Letter Confirming Co No Longer Considered Public In Taiwan
17/09/2020 23:18
Sept 17 (Reuters) - Aslan Pharmaceuticals Ltd 7A9y.F :
* ASLAN PHARMACEUTICALS - ON SEPT 17, RECEIVED TAIWAN'S
FINANCIAL
SUPERVISORY COMMISSION LETTER CONFIRMING CO NO LONGER CONSIDERED
PUBLIC CO IN TAIWAN
* ASLAN PHARMACEUTICALS - CO’S ADSS WILL CONTINUE TO BE
LISTED &
TRADED ON NASDAQ GLOBAL MARKET
Source : (https://bit.ly/3c7JMPW)
Further company coverage: 7A9y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aslan Pharmaceuticals
See all newsBrief: Aslan Pharmaceuticals Announces Plan To Implement ADS Ratio Change
Brief: Aslan Pharmaceuticals Ltd Files For Shelf Of Up To 61.9 Million Ordinary Shares By Selling Stockholder - SEC Filing
Brief: Aslan Pharmaceuticals Announces Expansion Of Its Collaboration With Zenyaku
Brief: Aslan Pharmaceuticals Announces Positive Interim Results From Phase 2 Study Of Eblasakimab
Brief: ASLAN Pharmaceuticals To Sell ADSs Having An Aggregate Offering Price Of Up To $12 Mln